Efficient and Stable PbS Quantum Dot Solar Cells by Triple-Cation Perovskite Passivation

Solution-processed quantum dots (QDs) have a high potential for fabricating low-cost, flexible, and large-scale solar energy harvesting devices. It has recently been demonstrated that hybrid devices employing a single monovalent cation perovskite solution for PbS QD surface passivation exhibit enhanced photovoltaic performance when compared to standard ligand passivation. Herein, we demonstrate that the use of a triple cation Cs0.05(MA0.17FA0.83)0.95Pb(I0.9Br0.1)3 perovskite composition for surface passivation of the quantum dots results in highly efficient solar cells, which maintain 96% of their initial performance after 1200 h shelf storage. We confirm perovskite shell formation around the PbS nanocrystals by a range of spectroscopic techniques as well as high-resolution transmission electron microscopy. We find that the triple cation shell results in a favorable energetic alignment to the core of the dot, resulting in reduced recombination due to charge confinement without limiting transport in the active layer. Consequently, photovoltaic devices fabricated via a single-step film deposition reached a maximum AM1.5G power conversion efficiency of 11.3% surpassing most previous reports of PbS solar cells employing perovskite passivation.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

ACS nano - 14(2020), 1 vom: 28. Jan., Seite 384-393

Sprache:

Englisch

Beteiligte Personen:

Albaladejo-Siguan, Miguel [VerfasserIn]
Becker-Koch, David [VerfasserIn]
Taylor, Alexander D [VerfasserIn]
Sun, Qing [VerfasserIn]
Lami, Vincent [VerfasserIn]
Oppenheimer, Pola Goldberg [VerfasserIn]
Paulus, Fabian [VerfasserIn]
Vaynzof, Yana [VerfasserIn]

Links:

Volltext

Themen:

Hybrid perovskite
Journal Article
Quantum dots
Solar cells
Solution-processing
Triple cation

Anmerkungen:

Date Revised 12.02.2020

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1021/acsnano.9b05848

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM303250836